Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director,...

33
Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University of Florida President, Policy Solutions Lab, Cambridge, MA www.kevinsabet.com

Transcript of Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director,...

Page 1: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Medical Marijuana Legalization

Issues: An Appeal for Reefer

Sanity

Kevin A. Sabet, Ph.D.Director, Drug Policy Institute and Assistant

Professor, University of Florida President, Policy Solutions Lab, Cambridge, MA

www.kevinsabet.com

Page 2: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

All or nothing?Legalization vs. Prohibition

Page 3: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.
Page 4: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Ultimately the Question is:

“Is the right to get high and buy legal marijuana in a store worth the risk to kids, society, and the economy in the

form of:• greater addiction and learning deficits• a new, legal industry relying on addiction

for profits • increased safety and health costs (like car

crashes or the costs to health care and the costs of a newly regulated system)

• compromising our scientific system in the name of politics and medicine a la public opinion”?

Page 5: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Is Marijuana Medicine?

NO: SMOKED OR INHALED RAW MARIJUANA IS NOT MEDICINE

YES: THERE ARE MARIJUANA-BASED PILLS AVAILABLE AND OTHER MEDICATIONS COMING SOON

MAYBE: RESEARCH IS ONGOING IN LOOKING AT MJ’s COMPONENTS

Page 6: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Bottom Line

We don’t smoke opium to get the effects of morphine.

So why would we smoke marijuana to get its potential

medical effects?

Page 7: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Bypassingthe FDA Process

Before FDA approves a drug as medicine, testing is done to:

Determine the Determine how it Assurebenefits and risks may interact with standardization

of the drug other drugs of the drug

Determine the Identify and Identifyappropriate monitor safe drug

dosage levels side effects administration

Page 8: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

FDA Determines Medicine“No sound scientific studies

supported medical use of marijuana for treatment in the United States,

and no animal or human data supported the safety or efficacy of marijuana for general medical use.

There are alternative FDA-approved medications in existence for

treatment of many of the proposed uses of smoked marijuana.”

Page 9: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Distinction must be made between raw, crude marijuana and marijuana’s components

So we should research marijuana’s components

Page 10: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Snapshot of Promising Research: Sativex

• Sativex is a drug, approved in Canada, the UK, and other parts of Europe for the treatment of MS Spasticity and Cancer Pain.

• It combines THC and CBD to eliminate the “high” from marijuana

Page 11: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Current Medical Marijuana Laws

• 17 States and D.C.

• They vary in degree and implementation– Started as “affirmative defense” for

marijuana use for medicinal purposes; or removal of criminal penalties if “medical” use is claimed

– Evolved into state-based production and distribution

• Rely not on the FDA, but unregulated businesses

Page 12: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

State Medical Marijuana Programs Increase Drug Use

• Two independent, peer-reviewed studies looking at medical marijuana states in the 2000s concluded that:

States with medical marijuana programs had an increased in marijuana use not

seen in other states

Cerda, M. et al. (2011). Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug and Alcohol Dependence. Found at http://www.columbia.edu/~dsh2/pdf/MedicalMarijuana.pdf. Wall, M. et al (2011). Adolescent Marijuana Use from 2002 to 2008: Higher in States with Medical Marijuana Laws, Cause Still Unclear, Annals of epidemiology, Vol 21 issue 9 Pages 714-716.

Page 13: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Increased access and availability lead to

decreased perceptions of harm and increased use

Page 14: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Effects of “Medical” Marijuana

• California• Oregon• Colorado

Page 15: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Compassionate careincreased access to marijuana?

<5%■ Less than 5% of card

holders havecancer, HIV/AIDS,or life-threatening diseases

■ 90% are registeredfor ailments suchas general pain or headaches

Page 16: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Compassionate care orincreased access to marijuana?

>80%■ Most card holders in

CA and CO are whitemen between theages of 17 and 35

■ No history of chronicillness

■ History of Alcoholand Drug Use

Page 17: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

California Profile• Average user: 32 y/o WM

– No history of chronic illness– History of cocaine and alcohol use

• Recent study by legalization advocates report : 44% of users received marijuana for “headaches”, similar number for “exhaustion”

• Fridays at 2:00 PM – Sundays at noon:– Primary foot traffic

Page 18: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Oregon

• 2011: Currently 49,337 registered individuals.• 10 physicians made 46% of all recommendations.

• There are 40 Patients under age 18.– 19 are age 17– 12 are age 16– 9 are under the age of 15

Page 19: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Medical Marijuana Registry by Debilitating Conditions

Severe pain

Muscle spasms

Severe nausea

Seizures

Cancer

Cachexia

HIV/AIDS

Glaucoma

Total Conditions

Severe pain 118,133

Muscle spasms 28,304

Severe nausea 15,972

Seizures 1,787

Cancer 2,646

Cachexia 1,653

HIV/AIDS 664

Glaucoma 1,116

Colorado

Page 20: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

• Listing conditions for which marijuana can be obtained, including “other conditions as determined in writing...”

Typical Medical Marijuana Legislation

Page 21: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

• Two tier system:

• Marijuana Stores

• Home-Grown Cultivation

Typical Medical Marijuana Legislation

Page 22: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

• In MA: can possess a 60-day supply of marijuana

• 60-day supply is not defined in proposed law

• 1 ounce = 60-120 joints• At 3 joints/day, 1 oz. = 20 days• So 60-day supply = 3 oz.• 3 oz = 180-360 joints

• Three times more than what is currently allowed in MA without arrest

But it could be more – as a day’s supply could be 5 joints…. Or more…..

How Much Marijuana is Medicine?

Page 23: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

• People could legally grow marijuana their homes.

Typical Medical Marijuana Legislation

Page 24: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

• Pot based products such as foods, oils, ointments, aerosols, may be legally sold as “medicine”.

Typical Medical Marijuana Legislation

Page 25: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

• No expiration date or limit on renewals for “recommendations”

• No age restrictions

• State Government would be charged to regulate marijuana dispensaries, card registration and statewide (users/growers free to start before DPH steps in)

• Federally Illegal System (state employees at risk of arrest)

Other outstanding issues

Page 26: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

That doesn’t mean that components in marijuana do not have medical properties.

These are being scientifically developed.

Page 27: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Let’s do medical marijuana the right

way• Determine all of the medicinal compounds in the marijuana plant.

• Determine which compounds are most effective for cancer patients, which are more effective for pain management, which are most effective for treating other diseases.

• Make them available to doctors and patients legitimately, at pharmacies.

Page 28: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

The Government Is Doing Research

• Robust marijuana research program conducted by the US Government– Not much interest from Pharma

• 209 active researchers registered with DEA to perform bona fide research with marijuana, marijuana extracts, and THC. – Every researcher who has put forth a valid research proposal

has received permission to study marijuana. – Studies include evaluation of abuse potential,

physical/psychological effects, adverse effects, therapeutic potential, and detection. 14 use smoked marijuana with humans

Page 29: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Marijuana-Based Medications

• NIH is responsible for research into marijuana-derived medications.

• 288 NIH-supported projects on cannabinoids.

• Scheduling less relevant– Cocaine is Schedule II, no “Dispensaries”

allowed– But it Would Be A Symbolic Victory for

Advocates– Need an individual FDA-approved product

for medical use

Page 30: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

A Compassionate Access Proposal

• Before marijuana-based medications become more widely available, offer marijuana, regulated in strength, purity, and composition, to:

• Cancer patients

• Terminally ill

• Those with MS, ALS, and AIDS whose bona fide physicians have recommended marijuana because other medications have not worked

Page 31: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

• 1978: Keith Stroup “We are trying to get marijuana reclassified medically. If we do that, (we'll do it in at least 20 states this year for chemotherapy patients) we'll be using the issue as a red herring to give marijuana a good name.”

• 2012: MASSCANN/NORML spokesman: “Stepping stone to legalization? I hope so. That’s the plan. Decrim 2008, Medical 2012, Legal 2016. Yes we want to legalize! We will completely legalize for everybody in 2016.”

What is this really about?

Page 32: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

Marijuana is NOT approved as medicine by:

• The FDA• The American Medical Association• The National Multiple Sclerosis Society• The American Glaucoma Society• The American Academy of Ophthalmology

• The American Cancer Society• The American Pediatric Society• The Massachusetts Medical Society

Page 33: Medical Marijuana Legalization Issues: An Appeal for Reefer Sanity Kevin A. Sabet, Ph.D. Director, Drug Policy Institute and Assistant Professor, University.

THANK YOU!KEVINSABET@GMAI

L.COMWWW.KEVINSABET.C

OM